<DOC>
	<DOCNO>NCT02609295</DOCNO>
	<brief_summary>This study evaluate whether ALA intake alters total cholesterol homeostatic factor relationship alteration lipoprotein associate phospholipase A2 ( Lp-PLA2 ) activity .</brief_summary>
	<brief_title>Effects α-linolenic Acid Supplementation Hemostasis Nondiabetic Hypercholesterolemic Subjects</brief_title>
	<detailed_description>An 8-week , randomize , double-blind , placebo-controlled study conduct 86 nondiabetic borderline-to-moderate hypercholesterolemic ( 200mg/dL ≤ serum cholesterol ≤ 300mg/dL ) subject , take medication supplement affect lipid metabolism , platelet function inflammation , divide two group : α-linolenic acid ( ALA ) group [ 1.2 g ( two capsule ) perilla oil daily ; 497 mg ALA ] placebo group ( 1.2 g medium-chain triglyceride oil daily ) .</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Perilla seed oil</mesh_term>
	<criteria>Voluntarily agree participate sign informed consent form Adults age 4070 Nondiabetic hypercholesterolemic subject ( serum cholesterol ≥ 200 mg/dL ) Subjects take medication supplement know affect lipid metabolism platelet function , n3 fatty acid supplementation n3 fatty acidrich fish two time per week Following disease : dyslipidemia , hypertension , diabetes , liver disease , renal disease , pancreatitis , cardiovascular disease , gastrointestinal disease , cancer , disease require treatment Participation clinical trial drug supplement within 30 day prior participation study Pregnant lactate woman , alcoholic , mental patient Judged inappropriate study investigator review reason</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>68 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>α-linolenic acid</keyword>
	<keyword>perilla oil</keyword>
	<keyword>aPTT</keyword>
	<keyword>Collagen-epinephrine closure time</keyword>
	<keyword>Lp-PLA2</keyword>
</DOC>